https://www.selleckchem.com/pr....oducts/rhosin-hydroc
397, P = 0.219; I 2 = 36.2%, P = 0.128] as those treated with delayed EVT. Delayed EVT was also associated with no significant difference in mortality (OR = 1.015, 95% CI = 0.852-1.209; P = 0.871; I 2 = 0.0%, P = 0.527), successful recanalization (OR = 1.255, 95% CI = 0.923-1.705; P = 0.147; I 2 = 60.5%, P = 0.009), and sICH (OR = 0.976, 95% CI = 0.737-1.293; P = 0.871; I 2 = 0.0%, P = 0.742) rates compared with early EVT. Conclusions Among selected patients with AIS, delayed EVT showed comparable outcomes in functional ind
Like
Comment
Share
